STAAR Surgical is trading 5.2% down at $22.86 today, following the announcement that Warren Foust has been appointed as its permanent President and Chief Executive Officer, effective August 4, 2026.
- Foust had been serving as interim co-CEO since February 2026.
- The company's second-quarter 2026 earnings release is scheduled for August 12, 2026.